BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11035928)

  • 1. F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.
    Chiba H; Chambon P; Metzger D
    Exp Cell Res; 2000 Nov; 260(2):334-9. PubMed ID: 11035928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
    Hayashi S; McMahon AP
    Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
    Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.
    Utomo AR; Nikitin AY; Lee WH
    Nat Biotechnol; 1999 Nov; 17(11):1091-6. PubMed ID: 10545915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible gene inactivation in neurons of the adult mouse forebrain.
    Erdmann G; Schütz G; Berger S
    BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetracycline-inducible gene expression and gene deletion in Candida albicans.
    Park YN; Morschhäuser J
    Eukaryot Cell; 2005 Aug; 4(8):1328-42. PubMed ID: 16087738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice.
    Juhila J; Roozendaal R; Lassila M; Verbeek SJ; Holthofer H
    J Am Soc Nephrol; 2006 Mar; 17(3):648-54. PubMed ID: 16467448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.
    Belteki G; Haigh J; Kabacs N; Haigh K; Sison K; Costantini F; Whitsett J; Quaggin SE; Nagy A
    Nucleic Acids Res; 2005 Mar; 33(5):e51. PubMed ID: 15784609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible transgenic mouse models.
    Saunders TL
    Methods Mol Biol; 2011; 693():103-15. PubMed ID: 21080277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation.
    Heidmann D; Lehner CF
    Dev Genes Evol; 2001 Sep; 211(8-9):458-65. PubMed ID: 11685583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Floxed reporter genes: Flow-cytometric selection of clonable cells expressing high levels of a target gene after tamoxifen-regulated Cre-loxP recombination.
    Spiotto MT; Schreiber H
    J Immunol Methods; 2006 May; 312(1-2):201-8. PubMed ID: 16674971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma brucei: a first-generation CRE-loxP site-specific recombination system.
    Barrett B; LaCount DJ; Donelson JE
    Exp Parasitol; 2004; 106(1-2):37-44. PubMed ID: 15013787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional gene activation in cultured hepatocytes using a ligand-dependent chimeric Cre recombinase.
    Zhu HZ; Cao YY; Cheng GX; Xue JL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 May; 35(5):435-40. PubMed ID: 12766804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible site-specific recombination in the brain.
    Kellendonk C; Tronche F; Casanova E; Anlag K; Opherk C; Schütz G
    J Mol Biol; 1999 Jan; 285(1):175-82. PubMed ID: 9878397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-inducible Cre-mediated recombination in adipocytes.
    Sassmann A; Offermanns S; Wettschureck N
    Genesis; 2010 Oct; 48(10):618-25. PubMed ID: 20715175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
    Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
    Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.
    Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF
    Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.